Campylobacter jejuni fatal sepsis in a patient with non-Hodgkin’s lymphoma

Case report and literature review of a difficult diagnosis

Maria Teresa Gallo, Enea Gino Di Domenico, Luigi Toma, Francesco Marchesi, Lorella Pelagalli, Nicola Manghisi, Fiorentina Ascenzioni, Grazia Prignano, Andrea Mengarelli, Fabrizio Ensoli

Research output: Contribution to journalArticle

Abstract

Campylobacter jejuni (C. jejuni) bacteremia is difficult to diagnose in individuals with hematological disorders undergoing chemotherapy. The cause can be attributed to the rarity of this infection, to the variable clinical presentation, and to the partial overlapping symptoms underlying the disease. Here, we report a case of a fatal sepsis caused by C. jejuni in a 76-year-old Caucasian man with non-Hodgkin’s lymphoma. After chemotherapeutic treatment, the patient experienced fever associated with severe neutropenia and thrombocytopenia without hemodynamic instability, abdominal pain, and diarrhea. The slow growth of C. jejuni in the blood culture systems and the difficulty in identifying it with conventional biochemical phenotyping methods contributed to the delay of administering a targeted antimicrobial treatment, leading to a fatal outcome. Early recognition and timely intervention are critical for the successful management of C. jejuni infection. Symptoms may be difficult to recognize in immunocompromised patients undergoing chemotherapy. Thus, it is important to increase physician awareness regarding the clinical manifestations of C. jejuni to improve therapeutic efficacy. Moreover, the use of more aggressive empirical antimicrobial treatments with aminoglycosides and/or carbapenems should be considered in immunosuppressed patients, in comparison to those currently indicated in the guidelines for cancer-related infections supporting the use of cephalosporins as monotherapy.

Original languageEnglish
Article number544
JournalInternational Journal of Molecular Sciences
Volume17
Issue number4
DOIs
Publication statusPublished - Apr 12 2016

Fingerprint

Campylobacter jejuni
Chemotherapy
infectious diseases
Non-Hodgkin's Lymphoma
Sepsis
chemotherapy
Carbapenems
Hemodynamics
Aminoglycosides
Cephalosporins
fever
hemodynamics
Blood
physicians
pain
blood
Campylobacter Infections
Drug Therapy
cancer
disorders

Keywords

  • Campylobacter jejuni
  • Chemotherapy
  • Non-Hodgkin’s lymphoma
  • Skin lesion

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Spectroscopy
  • Inorganic Chemistry
  • Catalysis
  • Molecular Biology
  • Computer Science Applications

Cite this

Campylobacter jejuni fatal sepsis in a patient with non-Hodgkin’s lymphoma : Case report and literature review of a difficult diagnosis. / Gallo, Maria Teresa; Di Domenico, Enea Gino; Toma, Luigi; Marchesi, Francesco; Pelagalli, Lorella; Manghisi, Nicola; Ascenzioni, Fiorentina; Prignano, Grazia; Mengarelli, Andrea; Ensoli, Fabrizio.

In: International Journal of Molecular Sciences, Vol. 17, No. 4, 544, 12.04.2016.

Research output: Contribution to journalArticle

Gallo, Maria Teresa ; Di Domenico, Enea Gino ; Toma, Luigi ; Marchesi, Francesco ; Pelagalli, Lorella ; Manghisi, Nicola ; Ascenzioni, Fiorentina ; Prignano, Grazia ; Mengarelli, Andrea ; Ensoli, Fabrizio. / Campylobacter jejuni fatal sepsis in a patient with non-Hodgkin’s lymphoma : Case report and literature review of a difficult diagnosis. In: International Journal of Molecular Sciences. 2016 ; Vol. 17, No. 4.
@article{c944e6ffc03547aa9ac9b4105f778cf6,
title = "Campylobacter jejuni fatal sepsis in a patient with non-Hodgkin’s lymphoma: Case report and literature review of a difficult diagnosis",
abstract = "Campylobacter jejuni (C. jejuni) bacteremia is difficult to diagnose in individuals with hematological disorders undergoing chemotherapy. The cause can be attributed to the rarity of this infection, to the variable clinical presentation, and to the partial overlapping symptoms underlying the disease. Here, we report a case of a fatal sepsis caused by C. jejuni in a 76-year-old Caucasian man with non-Hodgkin’s lymphoma. After chemotherapeutic treatment, the patient experienced fever associated with severe neutropenia and thrombocytopenia without hemodynamic instability, abdominal pain, and diarrhea. The slow growth of C. jejuni in the blood culture systems and the difficulty in identifying it with conventional biochemical phenotyping methods contributed to the delay of administering a targeted antimicrobial treatment, leading to a fatal outcome. Early recognition and timely intervention are critical for the successful management of C. jejuni infection. Symptoms may be difficult to recognize in immunocompromised patients undergoing chemotherapy. Thus, it is important to increase physician awareness regarding the clinical manifestations of C. jejuni to improve therapeutic efficacy. Moreover, the use of more aggressive empirical antimicrobial treatments with aminoglycosides and/or carbapenems should be considered in immunosuppressed patients, in comparison to those currently indicated in the guidelines for cancer-related infections supporting the use of cephalosporins as monotherapy.",
keywords = "Campylobacter jejuni, Chemotherapy, Non-Hodgkin’s lymphoma, Skin lesion",
author = "Gallo, {Maria Teresa} and {Di Domenico}, {Enea Gino} and Luigi Toma and Francesco Marchesi and Lorella Pelagalli and Nicola Manghisi and Fiorentina Ascenzioni and Grazia Prignano and Andrea Mengarelli and Fabrizio Ensoli",
year = "2016",
month = "4",
day = "12",
doi = "10.3390/ijms17040544",
language = "English",
volume = "17",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "4",

}

TY - JOUR

T1 - Campylobacter jejuni fatal sepsis in a patient with non-Hodgkin’s lymphoma

T2 - Case report and literature review of a difficult diagnosis

AU - Gallo, Maria Teresa

AU - Di Domenico, Enea Gino

AU - Toma, Luigi

AU - Marchesi, Francesco

AU - Pelagalli, Lorella

AU - Manghisi, Nicola

AU - Ascenzioni, Fiorentina

AU - Prignano, Grazia

AU - Mengarelli, Andrea

AU - Ensoli, Fabrizio

PY - 2016/4/12

Y1 - 2016/4/12

N2 - Campylobacter jejuni (C. jejuni) bacteremia is difficult to diagnose in individuals with hematological disorders undergoing chemotherapy. The cause can be attributed to the rarity of this infection, to the variable clinical presentation, and to the partial overlapping symptoms underlying the disease. Here, we report a case of a fatal sepsis caused by C. jejuni in a 76-year-old Caucasian man with non-Hodgkin’s lymphoma. After chemotherapeutic treatment, the patient experienced fever associated with severe neutropenia and thrombocytopenia without hemodynamic instability, abdominal pain, and diarrhea. The slow growth of C. jejuni in the blood culture systems and the difficulty in identifying it with conventional biochemical phenotyping methods contributed to the delay of administering a targeted antimicrobial treatment, leading to a fatal outcome. Early recognition and timely intervention are critical for the successful management of C. jejuni infection. Symptoms may be difficult to recognize in immunocompromised patients undergoing chemotherapy. Thus, it is important to increase physician awareness regarding the clinical manifestations of C. jejuni to improve therapeutic efficacy. Moreover, the use of more aggressive empirical antimicrobial treatments with aminoglycosides and/or carbapenems should be considered in immunosuppressed patients, in comparison to those currently indicated in the guidelines for cancer-related infections supporting the use of cephalosporins as monotherapy.

AB - Campylobacter jejuni (C. jejuni) bacteremia is difficult to diagnose in individuals with hematological disorders undergoing chemotherapy. The cause can be attributed to the rarity of this infection, to the variable clinical presentation, and to the partial overlapping symptoms underlying the disease. Here, we report a case of a fatal sepsis caused by C. jejuni in a 76-year-old Caucasian man with non-Hodgkin’s lymphoma. After chemotherapeutic treatment, the patient experienced fever associated with severe neutropenia and thrombocytopenia without hemodynamic instability, abdominal pain, and diarrhea. The slow growth of C. jejuni in the blood culture systems and the difficulty in identifying it with conventional biochemical phenotyping methods contributed to the delay of administering a targeted antimicrobial treatment, leading to a fatal outcome. Early recognition and timely intervention are critical for the successful management of C. jejuni infection. Symptoms may be difficult to recognize in immunocompromised patients undergoing chemotherapy. Thus, it is important to increase physician awareness regarding the clinical manifestations of C. jejuni to improve therapeutic efficacy. Moreover, the use of more aggressive empirical antimicrobial treatments with aminoglycosides and/or carbapenems should be considered in immunosuppressed patients, in comparison to those currently indicated in the guidelines for cancer-related infections supporting the use of cephalosporins as monotherapy.

KW - Campylobacter jejuni

KW - Chemotherapy

KW - Non-Hodgkin’s lymphoma

KW - Skin lesion

UR - http://www.scopus.com/inward/record.url?scp=84963744211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963744211&partnerID=8YFLogxK

U2 - 10.3390/ijms17040544

DO - 10.3390/ijms17040544

M3 - Article

VL - 17

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 4

M1 - 544

ER -